These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 23642357)

  • 1. Same function, different origins: multipotent stromal precursors in lymphoid tissues.
    Boehm T
    Cell Stem Cell; 2013 May; 12(5):501-3. PubMed ID: 23642357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine/stromal cell networks and lymphoid tissue environments.
    Fritz JH; Gommerman JL
    J Interferon Cytokine Res; 2011 Mar; 31(3):277-89. PubMed ID: 21133813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.
    Li F; Whyte N; Niyibizi C
    Biochem Biophys Res Commun; 2012 Oct; 426(4):475-9. PubMed ID: 22960177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of stem cells.
    Wada N; Gronthos S; Bartold PM
    Periodontol 2000; 2013 Oct; 63(1):198-216. PubMed ID: 23931061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise review: multipotent mesenchymal stromal cells in blood.
    He Q; Wan C; Li G
    Stem Cells; 2007 Jan; 25(1):69-77. PubMed ID: 16973831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bone marrow stromal cells simultaneously support B and T/NK lineage development from human haematopoietic progenitors: a principal role for flt3 ligand in lymphopoiesis.
    Nakamori Y; Liu B; Ohishi K; Suzuki K; Ino K; Matsumoto T; Masuya M; Nishikawa H; Shiku H; Hamada H; Katayama N
    Br J Haematol; 2012 Jun; 157(6):674-86. PubMed ID: 22463758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid stroma in the initiation and control of immune responses.
    Mueller SN; Ahmed R
    Immunol Rev; 2008 Aug; 224():284-94. PubMed ID: 18759934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation recapitulates the ontogeny of lymphoid stromal cells.
    Peduto L; Dulauroy S; Lochner M; Späth GF; Morales MA; Cumano A; Eberl G
    J Immunol; 2009 May; 182(9):5789-99. PubMed ID: 19380827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of the immune system of fish.
    Zapata A; Diez B; Cejalvo T; Gutiérrez-de Frías C; Cortés A
    Fish Shellfish Immunol; 2006 Feb; 20(2):126-36. PubMed ID: 15939627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining xanthan and chitosan membranes to multipotent mesenchymal stromal cells as bioactive dressings for dermo-epidermal wounds.
    Bellini MZ; Caliari-Oliveira C; Mizukami A; Swiech K; Covas DT; Donadi EA; Oliva-Neto P; Moraes ÂM
    J Biomater Appl; 2015 Mar; 29(8):1155-66. PubMed ID: 25281644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental factors unveil dormant developmental capacities in multipotent progenitors of the trunk neural crest.
    Coelho-Aguiar JM; Le Douarin NM; Dupin E
    Dev Biol; 2013 Dec; 384(1):13-25. PubMed ID: 24099925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the bone marrow with activin A-overexpressing embryonic multipotent stromal cells specifically modifies B lymphopoiesis.
    Parameswaran R; Morad V; Laronne A; Rousso-Noori L; Shani N; Naffar-Abu-Amara S; Zipori D
    Stem Cells Dev; 2008 Feb; 17(1):93-106. PubMed ID: 18225977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caught in the act: reprogramming of adipocytes into lymph-node stroma.
    Boehm T
    Immunity; 2012 Oct; 37(4):596-8. PubMed ID: 23084355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation.
    Morad V; Pevsner-Fischer M; Barnees S; Samokovlisky A; Rousso-Noori L; Rosenfeld R; Zipori D
    Stem Cells; 2008 Sep; 26(9):2275-86. PubMed ID: 18556513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
    Reinders ME; Fibbe WE; Rabelink TJ
    Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of mesenchymal stromal cells.
    Brooke G; Cook M; Blair C; Han R; Heazlewood C; Jones B; Kambouris M; Kollar K; McTaggart S; Pelekanos R; Rice A; Rossetti T; Atkinson K
    Semin Cell Dev Biol; 2007 Dec; 18(6):846-58. PubMed ID: 18024097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 induces the lineage commitment of bone marrow-derived mesenchymal multipotent cells through down-regulation of Sox2 by osteogenic transcription factors.
    Yoon DS; Kim YH; Lee S; Lee KM; Park KH; Jang Y; Lee JW
    FASEB J; 2014 Jul; 28(7):3273-86. PubMed ID: 24719354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of multipotent mesenchymal stromal cell aging.
    Stochaj U; Kodiha M; Shum-Tim D; Colmegna I
    Regen Med; 2013 Mar; 8(2):211-22. PubMed ID: 23477400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenic stromal niches support hematopoiesis of dendritic-like cells from precursors in bone marrow and spleen.
    Periasamy P; Tan JK; Griffiths KL; O'Neill HC
    Exp Hematol; 2009 Sep; 37(9):1060-71. PubMed ID: 19539692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoid potential of primitive bone marrow progenitors evaluated in vitro.
    Wang H; Pierce LJ; Spangrude GJ
    Ann N Y Acad Sci; 2005 Jun; 1044():210-9. PubMed ID: 15958714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.